Skip to content

Fecal microbiota transplantation combined with human intestinal fluid transplantation in children with autism: a single-center, open-label, randomized controlled study

Fecal microbiota transplantation combined with human intestinal fluid transplantation in children with autism: a single-center, open-label, randomized controlled study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100050346
Enrollment
Unknown
Registered
2021-08-26
Start date
2022-01-01
Completion date
Unknown
Last updated
2022-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism

Interventions

Intervention group:FMT and HIFT capsules

Sponsors

Shanghai Tenth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 13 Years

Inclusion criteria

Inclusion criteria: 1.Aged 3 to 13 years, male or female; 2.Meeting the ASD diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) of the American Psychiatric Association; 3.Accompanied with diarrhea, constipation, abdominal distension and/or food allergy/intolerance for at least 6 months and above symptoms occurred in the last 3 months; 4.Informed consent was signed by the subjects and/or guardians, and clinical data and peripheral blood, saliva, urine and feces samples were collected throughout the clinical trial; 5.Able to swallow 3# capsules by themselves.

Exclusion criteria

Exclusion criteria: 1.The diagnosis was Reiter's syndrome. 2.Previous history of brain injury, cerebral palsy, encephalitis or other brain organic diseases; 3.Diagnosis of other mental diseases; 4.Diagnosis of intestinal organic diseases, such as congenital megacolon, intestinal obstruction, intussusception, inflammatory bowel disease and etc.; 5.There are pathological intestinal inflammatory changes, such as inflammatory bowel disease; 6.Severe obesity or severe malnutrition; 7.Using probiotics, antibiotics and other drugs affecting intestinal flora in a planned way within the last 3 months or in the following 6 months; 8.Have received FMT treatment in the last 12 months.

Design outcomes

Primary

MeasureTime frame
Childhood Autism Rating Scale;

Secondary

MeasureTime frame
Autism Behavior Checklist;Bristol Stool Form Scale;Gastrointestinal Symptom Rating Scale;Patient Generated Index;Social Anxiety Scale for Children;Children's Depression Inventory;

Countries

China

Contacts

Public ContactChen Qiyi

Shanghai Tenth People's Hospital

qiyichen2011@163.com+86 15896453859

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026